10-12-2021, 01:29 PM
(This post was last modified: 10-12-2021, 02:01 PM by dirkfansince1998.)
So the goal post moved from HXQ is the cure. To Ivermectin is the cure. First randomized controlled studies are used to make a case for Ivermectin and when those studies are facing criticism and even fraud allegations. Are retracted or at least removed from meta-analysis. We are moving the goal post again. Let´s ignore that the mentioned studies (for example Elgazza, Carvallo) are questioned because of the very same issues that are mentioned in the linked abstract. All of a sudden we should just ignore the results of other RCT and focus on observational studies which can be of higher or lower quality as well.
Quick advice. Don´t give up on the randomized double blind approach just yet. We are waiting for the results of two studies. Maybe they will find a benefit. Maybe they won´t.
Can already tell what happens if they don´t find evidence for the benefit of Ivermectin. We will move on again. Promote a new cure. My best guess. Budesonid. Probably the most promising option among the three mentioned drugs.
Quick advice. Don´t give up on the randomized double blind approach just yet. We are waiting for the results of two studies. Maybe they will find a benefit. Maybe they won´t.
Can already tell what happens if they don´t find evidence for the benefit of Ivermectin. We will move on again. Promote a new cure. My best guess. Budesonid. Probably the most promising option among the three mentioned drugs.